\"Investment that drives transformation\"

Labat Healthcare

Labat Africa Group > Labat Healthcare
Labat Healthcare Logo

About Us

The lion is passion, the lion is the fire. Lions call you to them.
MICHAEL SAMUELS

The Labat Africa Board have made the strategic decision to transition the business from an investment holding company into a fully Integrated cannabis business with a focus on healthcare, wellness and industrial hemp. Labat Africa Limited has developed a complete repositioning strategy which is currently being implemented. The company has made a number of acquisitions in the cannabis space, as well as forming strategic partnerships to reach its goal of becoming the a market leader in the medicinal and industrial cannabis space by focusing on utilizing world-class scientific processes, the best human resources, strategic partnerships with market leaders, the best available medical skills, technology, formulations and intellectual property.

Completed Acquisitions

In line with the new strategy Labat Africa Limited has already completed the following acquisitions

  • Sweetwater Aquaponics – A GACP, GMP and SAHPRA approved cannabis cultivation and processing facility.
  • CannAfrica – A retail business which manufactures a wide range of CBD infused health and wellness products.
  • The Highly Creative – A company that owns IP such as Genetics, technology and processes as well as a R2.1bn offtake agreement.
  • Biodata – A research company with a focus on using cannabis as treatment for patients for a variety of ailments.
  • African Cannabis Enterprises (ACE Genetics) – a cannabis company which owns various genetics and currently trades in cannabis raw materials.
  • Echo Life – a Miami owned CBD Health and Wellness Company.

Executive Team

Stanton van Rooyen

Chief Executive Officer Labat Healthcare

Stanton Van Rooyen has been working for Labat Africa Limited for seven years holding a variety of positions most recently business development manager of the Labat Africa Limited group, he set up the logistics division of Labat, and is currently the CEO of Labat Bulk Logistics. Stanton will bring with business development and management knowledge and experience.

Herschel Maarsdorp

Labat Healthcare Group Executive – Business Development

Herschel is an entrepreneur, with a primary degree in the UWC Faculty of Community & Health Sciences, and Postgraduate qualifications in Development Economics (UWC) and Logistics (University of Ecuador & University of Liege). His strengths are in Strategic Planning, Stakeholder Analysis, Business Management and Project Management. He served as Project Director of International Benchmarking for Chemical Industries at CHIETA as well as Project Director for Marketing and Feasibility Studies for the Dutch organisation EVD (international cooperation & economic development). He Previously served as Chairman of the Nelson Mandela Presidential Jobs Summit on the SMME Implementation Committee, the Chairman of the Dutch Chamber of Commerce and as Chairman of the National Committee for the Assessment of Reforms of Public Procurement to the SMME sector in South Africa.

Medical Research & Science

Dr Shiksha Gallow

Medical and Technical Director

Dr Gallow is the Principal Investigator for the first medical cannabis trial in South Africa at Biodata, a medical research company she founded. Dr Gallow is also the Medical Director of Holistic Integrative Healing Institute, as well as a shareholder at a SAHPRA licenced medical cannabis facility in the Eastern Cape, which was one of the first medical cannabis licences in the province. She has vast academic qualifications in both the medical sector, public health and strategic management. Dr Gallow is registered with the HPCSA in Clinical Pathology as a Medical Scientist, and is an Ethnomedicine and Ayurvedic Practitioner. She has been appointed on the Board of Directors for the Society of Cannabis Clinicians in the UK and US. She holds a Masters Degree in Medical Science (MMedSci), a Masters in Medicine in Public Health Medicine (MMedMPH), Masters in Business Admin (MBA), a PHD, completed her Clinical Pathology medical board exam, completed a Medical Cannabis accredited course with the University of Washington Medical School, and a Diploma in Medical Cannabis. The Universities she obtained her degrees include, Durban University, University of Roehampton UK, Open University UK, Milton Keynes University UK, University of Washington Medical School, UNISA and the MBA was affiliated with HARVARD University. In addition, she is also a qualified trainer, assessor and moderator with SETA as well as a Prince 2 Practitioner registered with APMG. Dr Gallow has also recently published two academic books internationally one in the field of Medicine and the other in Business.

Labat Healthcare – Group Structure